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In 2012 the Choose Wisely campaign was launched in the United States in order to address 
concerns regarding medicalisation, over diagnosis and medical consumerism. The campaign 
has now spread internationally and includes a number of countries including Canada, 
Australia, New Zealand and Germany.  The primary aim of the campaign is to facilitate 
healthcare professionals and patients to question the overall utility of medical interventions. 
Professionals through their professional organisations identify at least five commonly used 
interventions or tests, within their areas of speciality, which they feel provided no or little 
benefit to patients.  
This paper provides the background to the Choose Wisely campaign. The paper reviews the 
concepts of medicalisation, over diagnosis and medical consumerism, before considering the 
utility of the campaign in the UK alongside other forms of governance such as NICE. The paper 
goes on to consider distributive justice as the principal ethical issue related to the campaign. 
The paper concludes by asking if UK based Physiotherapists should Choose Wisely. 
Contribution of the paper: 
This paper 
 Opens the debate about low value care within physiotherapy in the UK 
 Provides background information to the Choose Wisely campaign 
 Considers the ethical issues for UK based Physiotherapists being involved in the 
Choose Wisely campaign 
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Set against a backdrop of increasing concerns about the sustainability of healthcare funding, 
a campaign has begun which aims to encourage healthcare professionals to think carefully 
about the clinical and cost effectiveness of the investigations and interventions they use. 
Titled Choose Wisely, the campaign was initiated in the United States and has spread to a 
number of countries including Canada, Australia, Japan, Germany and France (1).  This paper 
aims to provide an overview of the Choose Wisely campaign, including the key concepts, 
which underpin its development. In addition, it will provide a critical discussion of the ethics 
of the campaign within a UK context with the aim of initiating debate around the question 
“Should UK Physiotherapists Choose Wisely?” 
The Choose Wisely campaign can be traced back to 2009 (2).The National Physicians Alliance, 
a US based organisation promoting professional integrity and health justice, supported 
volunteers from three primary care specialities to identify at least five commonly used 
interventions or tests, within their areas of speciality, which they felt provided no or little 
benefit to patients (3). In 2012 the Choose Wisely campaign was launched and professional 
organisations in a number of countries have subsequently developed lists of tests or 
interventions which they feel offer no significant medical benefit, or that offer similar 
outcomes to other less expensive options. Low value care is the term commonly used to 
describe such procedures (4). The primary aim of the Choose Wisely campaign is to facilitate 
healthcare professionals and patients to question the overall utility of medical interventions. 
As a result, once lists have been developed, they are disseminated to patients via what has 
been termed “consumer partners”; in the UK this dissemination is currently via the BMJ (1). A
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The Choose Wisely campaign has come about in part because of three key concerns. These 
are medicalisation, over diagnosis and medical consumerism, and they have been brought to 
the fore by a number of publications produced over the past 10 years (5; 6).  
Firstly, there is a growing awareness of the effects of medicalisation and how these processes 
influence society’s’ and individuals’ views of health and illness. Medicalisation is a term used 
to describe the processes through which non-medical elements of life are turned into medical 
problems.  
Sociologists have been interested in the role medicine plays in society for some time and have 
shown that, over the years, a number of social phenomena have come to be seen as medical 
conditions and alternatively some have not. There are also contested illness, where sufferers 
claim they have symptoms yet there is disagreement as to the legitimacy of these claims from 
a medical perspective, examples of these include chronic fatigue syndrome and fibromyalgia 
(7). The interplay between medicine and society has and continues to be fluid and dynamic. 
Medicine has a role in legitimising or refuting social roles, as Illich (8 p. 53) describes, “disease 
takes its features from the physician who casts the actors into one of the available roles”, sick 
or not sick. Of importance in the context of the Choose Wisely campaign is the recognition 
that the processes of medicalisation are now not the sole remit of medical professionals and 
that there is growing evidence of medicalisation by biotechnology industries, insurance 
companies and consumer groups (9). 
The second concern driving the Choose Wisely campaign is termed over-diagnosis (10). Over 
diagnosis has been defined as “diagnosing a biomedical condition that in the absence of 
testing would not cause symptoms or death” (11). Within the context of Choose Wisely, over 
diagnosis has been expanded to include the use of tests or investigations which add little to 
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the overall management of a condition (12). Moynihan et al (10) have presented evidence 
suggesting the over diagnosis of a number of conditions ranging from breast cancer (13) to 
asthma (14). In addition, Moynihan et al (10) have identified several drivers for over diagnosis 
in contemporary healthcare. These include technological advancements, which mean that 
small and often benign abnormalities can now be identified and thus treated (even if they 
may not actually require treatment), financial incentives for patients (for example insurance 
claims) and professionals (in non-state funded health economies) and/or health systems 
where there is a fear of litigation.  
In the context of Physiotherapy, the use of imaging for patients with non-specific low back 
pain has been cited as an example of over diagnosis as the results will invariably have little or 
no effect on the subsequent intervention(s) (15; 16).  
A final concept which has prompted professional organisations across the globe to sign up to 
the Choose Wisely campaign is medical consumerism (17). It could be argued that 
medicalisation and over diagnosis are symptoms of the broader concept of medical 
consumerism. In some areas of the world there is over consumption of healthcare. Healthcare 
is an economy and the role of pharmaceutical and medical equipment companies in the 
development of new, and maintenance of existing, markets is well documented ( 17). In 
addition (and perhaps as a result of), contemporary society’s attention to the body and health 
as a form of social capital has fuelled in part the perceived need for individuals to access 
medical products that prolong what is considered a “good” body and “good” health. Good 
meaning young, active and free from conditions associated with old age. 
In order to tackle the issues of medical consumerism, over diagnosis and medicalisation, 
Choose Wisely is asking clinicians to produce lists of at least five tests or interventions which 
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they feel offer little or no benefit and/or are not cost effective. Within Physiotherapy the 
American Physical Therapy Association (18), and the Australian Physiotherapy Association 
(16) have adopted the campaign. Both professional organisations, following the 
recommendations of the Choose Wisely campaign have, through consultation with their 
members and a review of the available empirical evidence, identified tests and interventions, 
which they feel constitute low value care.  The two lists are not identical in content and vary 
in their use of language. The APTA has produced a list of 12 interventions and tests which they 
feel offer little or no value and have presented these as a “don’t use” edict. Examples from 
the APTA’s list are “Don’t use (superficial or deep) heat to obtain clinically important long 
term outcomes in musculoskeletal conditions” and “Don’t use ultrasound to reduce swelling, 
promote joint healing, or achieve long-term pain relief for musculoskeletal conditions” (18). 
In contrast, the APA’s list comprises 6 recommendations, and is presented in parts in a less 
dictatorial fashion. Their list contains the term avoid as well as don’t, for example “Avoid using 
electrotherapy modalities in the management of patients with LBP” (16). As mentioned, the 
lists are not identical, which Traeger et al (16) have suggested may be a reflection of 
“international differences in scope of practice, international differences in which low-value 
interventions are used, a lack of consensus on the most important low value physiotherapy 
practices to address, or differences in the way that lists are developed between countries." 
The lists are not without criticism, for example, the use of electrotherapy for common 
conditions such as low back pain is something that remains contested (19).  
The primary aim of the Choose Wisely campaign is to reduce or eliminate “low value care”. 
Brody has suggested that when considering items to be included in any recommendations for 
de-implementation, practitioners should identify interventions or tests which are  “commonly 
ordered, are among the most expensive, and have not been shown by evidence to provide 
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meaningful benefit to at least some major categories of patients” (20, p. 284). Although this 
definition has been largely adopted by the Choose Wisely campaign, it has been criticised as 
being too superficial (21), for example, what is common, how expensive does something have 
to be in order for it to be considered costly and finally what is meant by evidence of 
effectiveness? 
In order to expand upon these points Blumenthal-Barby (21) has furthered the definition of 
low value care by asking a series of questions in relation to frequency, cost and evidence. For 
example, it may be that an intervention has an underdeveloped evidence base; however, it is 
low cost or the only option available and therefore would not equate to low value care. 
Unpacking the concept of low value care as defined within the Choose Wisely campaign brings 
familiar issues within Physiotherapy practice to the fore, namely evidence of cost and clinical 
effectiveness.  
Although difficult to measure (22), and define (23) the cost effectiveness of interventions has 
traditionally been assessed based on the amount spent against the resulting quality-adjusted 
life years (QALYs) gained (24). The value of an intervention is therefore seen as its actual or 
potential outcome relative to its overall cost. A difficulty for Physiotherapy is that our 
contribution to the patient’s overall health outcome is often as part of a process of care as 
opposed to a singular intervention and as a result the costs involved are often elusive. 
A more accessible source of information from which to determine the value of a test or 
intervention is to look at its supporting evidence base (25). The value of “evidence” in 
determining clinical decisions remains contentious (26), arguments around the leverage of 
evidence, the devaluing of tacit knowledge and a lack of patient centeredness continue (27). 
In addition there is the recognition that some of the drivers behind the Choose Wisely 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
7 
 
campaign, namely over diagnosis and medicalisation, are in part as a result of the evidence 
based movement (27). 
In the UK context the National Institute of Health and Clinical Effectiveness (NICE) advises 
clinicians on best practice through the production of clinical guidelines. The primary focus of 
NICE therefore is to inform practitioners, commissioners and the general public, what tests or 
interventions should be done not what should not be done. Almost as a by-product of its 
review of the evidence base NICE does however, produce recommendations about 
interventions and tests which should not be offered. An example is the current NICE guidance 
on the management of low back pain and sciatica, in which it is recommended that 
acupuncture, electrotherapy and traction should not be offered to patients (28). Although 
NICE makes recommendations as to which interventions or tests not to offer this is not its 
primary focus and as such differs from the Choose Wisely campaign whose primary intent is 
to identify what not to do.  
Aside from the debates about evidence-based practice, there are two important areas, which 
need further discussion. The first are the potential political issues regarding the identification 
of procedures, which we feel, are of no value, and the second are the moral implications of 
being involved in the campaign. 
In the UK, the Choose Wisely campaign is being co-ordinated by the Academy of Medical Royal 
Colleges.  Although the evidence is limited there are suggestions that the Choose Wisely 
campaign could be utilised by professional groups as a means of professional protectionism 
(3) and potential attack. Analysing the lists produced by the medical societies in the US, 
Morden et al (3) identified variation with regards to the costs and potential impacts of the 
types of procedures identified across the different medical specialities.  Strikingly, Morden et 
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al (3) identified that most societies generated lists containing procedures or tests commonly 
done by other specialities as opposed to their own and as such utilised the exercise to identify 
low value care within the work of competitive specialities. What the work of Morden et al (3) 
highlights is the political and perhaps financial drivers behind decisions related to healthcare 
resource allocation.  
Underpinning the political issues regarding the campaign are the moral implications of being 
involved. Choose Wisely is asking professionals, through their professional organisations, to 
identify procedures which they feel are of low value. At an individual level when working with 
our patients, we make decisions regarding the value of an intervention for a particular patient 
on a daily basis. This is reflected in our professional and regulatory body’s standards of 
practice. We have a responsibility as autonomous practitioners to ensure the quality of our 
practice ( 29; 30) and we do this by making a judgement based on our assessments as to what 
treatment would work “best” for our patients. The Choose Wisely campaign, however is not 
asking us to make decisions about the value of the care we offer individual patients, rather it 
is asking professionals to make judgements about the value of interventions and tests at a 
population level (macro-allocation). These two decisions are not the same and therefore 
require further exploration. 
 
Decisions made at the micro allocation level reflect a process close to that described by 
Kerridge et al (31) in that as practitioners we draw on a diverse knowledge base and where 
possible, aim to involve the patient as much as possible in the process. The ethical principle 
of autonomy (the patients) is given primacy in such a process (32). As a result some have 
argued that it would be unethical to consider the wider social needs related to healthcare 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
9 
 
resource distribution (33). Acknowledging this, however, Wolfson et al (4) make the argument 
that as healthcare professionals we have a moral and professional responsibility to promote 
“the just distribution of finite resources”, and as such have a moral and professional 
responsibility to engage with a campaign such as Choose Wisely (34).  
Making decisions about which treatments should be available and which should not at a 
population level brings clinicians directly into conversations about resource distribution 
specifically and justice generally. When we consider the concept of justice, it is important to 
make it explicit that within health care, we are primarily concerned with recourse allocation 
or what has been termed “distributive justice” (35). This differentiation is important as the 
types of decisions made, and the normative factors considered, may differ if we were 
considering for example legal justice. 
Although there is no agreed definition (35) one interpretation of justice is that it represents a 
moral agreement based upon the consideration of competing criteria. As a concept justice is 
temporal and contextual (based upon normative criteria) however, it should be seen to be fair 
i.e. mutually agreed (35). 
 
There are a number of ethical theories of justice, however in the context of Choose Wisely 
only three will be considered as these are seen as the most pertinent to the discussion.  It is 
important to recognise that the Choose Wisely campaign is asking healthcare professionals to 
answer two questions, what treatments should not be made available and who should not 
receive them.  
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Egalitarian (which takes the view that all people are equal) interpretations of justice aim to 
maximise the overall good and as such the “standard of justice depends on the principle of 
utility” (the usefulness of the action/decision for the majority) (36, p. 231). A major criticism 
of this approach is that by focusing on the best outcome for the majority we neglect individual 
liberties (35). For example, some patients may benefit psychologically from electrotherapy for 
their low back pain, but by placing it on a list of “Don’t use”, then we could be seen to be 
infringing on their freedom of choice. Libertarian (advocating free will) theories in contrast 
focus on an individual’s autonomy. An important contributor to this set of theories is Robert 
Nozick (37), who, through the development of what is termed “entitlement theory”, suggests 
that a just society is one that protects an individual’s liberty. With freedom, an individual has 
opportunity, and with this can make social gains for example healthcare. Again, by placing an 
intervention on a list, which makes it unavailable for patients, you are as before affecting their 
individual liberty. Finally, Rawls theory of Justice (38) attempts to combine egalitarianism with 
libertarian interpretations of justice. Although Rawls did not write specifically about 
healthcare distribution Daniels (39) has interpreted his theory of justice in the context of 
health. Daniels argues that in order for there to be equality of opportunity i.e. liberty then 
individuals have to be free from ill health as the latter can prevent the former. Inequalities in 
health can only be tolerated if they are because of factors other than socio-economic factors. 
Both Daniels and Rawls acknowledge however, that even in the most egalitarian societies 
decisions have to be made about resource distribution. In order to address the ethical issues 
presented by healthcare resource distribution (rationing), Daniels and Sabin (40), drawing on 
Rawls work, developed the concept of “accountability for reasonableness”, a concept which 
requires decision making to be open to “democratic deliberation”.  
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NICE, in the construction of its guidance, draws on accountability for reasonableness  
principles in order to ensure that the decisions made with regards to resource distribution 
have moral validity. Unfortunately, the lists developed as part of the Choose Wisely campaign 
lack such transparency, although recent developments are addressing this (41). 
As mentioned, the Academy of Medical Royal Colleges is leading the campaign in the UK. In 
the development of lists the Academy recommends that members utilise NICE guidance in 
order to cross-reference any recommendations identified within their do not do lists. An 
importance question for UK based Physiotherapists considering joining the Choose Wisely 
campaign is, therefore, does it offer anything different to what we already have through our 
current governance mechanisms? The answer is yes and no. No because NICE already 
(indirectly) offer guidance about interventions that lack evidence of effectiveness; and yes 
because the focus of NICE is too broad and focuses on value as opposed to low value. 
The moral utility of the Choose Wisely campaign is open to question and in the UK we have 
some governance mechanisms which review the effectiveness of common healthcare 
interventions. With this said, however, the Choose Wisely campaign offers practitioners 
through their professional organisations, the opportunity to focus on specific areas related to 
their practice and more importantly to look critically at the value of the interventions they 
offer. The Campaign is growing internationally (42), taking the points raised in this paper, it 
would be prudent to ask the question “Should UK Physiotherapists Choose Wisely? 
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